🧩Step 4 — Concept Integration

1. THE TOPIC IN ONE CONNECTED FLOW

Bleeding per rectum may result from a localized vascular or anorectal lesion, intestinal inflammation, or colorectal malignancy. The first decision is whether the patient is stable. Next, the symptom pattern and investigations identify the cause. Inflammatory bowel disease connects mucosal injury to bleeding, while prolonged colonic inflammation also influences cancer surveillance and long-term care.

Presentation

Hematochezia, bloody diarrhea, urgency, altered bowel habit or anemia

→

Assess severity

Instability or major bleeding → resuscitate first; stable → targeted evaluation

→

Find the mechanism

Bleeding lesion, mucosal UC, transmural Crohn’s or neoplastic growth

→

Confirm & stage

CBC, stool studies, colonoscopy/biopsy; CT angiography for active major bleeding; cancer staging imaging

→

Treat the cause

Hemostasis; severity-appropriate IBD medicines or surgery; stage-based cancer treatment

→

Prevent harm

Watch for shock, toxic megacolon, obstruction, abscess, thrombosis and dysplasia; arrange follow-up

2. KEY CLINICAL CONNECTIONS

Bleeding: pattern → priority

Large ongoing hematochezia + tachycardia or hypotension → possible major hemorrhage → resuscitation and urgent localization (often CT angiography).

Persistent bleeding + weight loss, altered bowel habit or iron-deficiency anemia → investigate for colorectal cancer, even when hemorrhoids are present.

IBD wall depth → complications

UC: continuous mucosal inflammation from rectum → blood, urgency and tenesmus → mesalazine for mild disease; IV steroids for acute severe attacks.

Crohn’s: skip lesions and transmural inflammation → strictures, fistulas and abscesses → medical therapy plus intervention when structural or infected complications occur.

Diagnosis → treatment planning

Colonoscopy + biopsy → confirm colorectal cancer → CT chest/abdomen/pelvis for spread; pelvic MRI adds local staging in rectal cancer.

Tumor site and TNM stage → surgery ± systemic treatment; selected locally advanced rectal cancers need neoadjuvant therapy.

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ Unstable hematochezia → immediate resuscitation; persistent major bleeding may require CT angiography, embolization or surgery.

Blood with urgency and tenesmus → suspect colitis; stool infection tests and colonoscopic biopsies help establish the diagnosis.

⭐ UC: rectal, continuous, mucosal → distal bleeding and urgency; rectal mesalazine treats proctitis, while more extensive mild disease often benefits from oral plus rectal mesalazine.

IBD steroid treatment → rapid control of a flare, not maintenance; selected steroid-dependent patients need steroid-sparing therapy and drug-safety monitoring.

⭐ Acute severe UC → admission and IV steroids; poor early response triggers rescue-treatment and colectomy decisions. Dilatation with perforation requires emergency surgery.

Transmural Crohn’s disease → abscesses need infection control/drainage; fixed fibrotic strictures may need dilatation or surgery, which does not cure Crohn’s.

Long-standing colonic inflammation → dysplasia/cancer risk → surveillance colonoscopy; new bleeding, anemia or changed bowel habit also warrants evaluation.

⭐ Colorectal carcinoma → biopsy confirms, CT stages distant spread, MRI stages rectal local extension; stage III colon cancer commonly needs surgery plus adjuvant chemotherapy, while locally advanced rectal cancer may need preoperative therapy.

Concept Integration — Topic 7